DK1849774T3 - Cyclohepta(b)pyridin-3-carbonylguanidinderivat og farmaceutisk produkt indeholdende samme - Google Patents
Cyclohepta(b)pyridin-3-carbonylguanidinderivat og farmaceutisk produkt indeholdende sammeInfo
- Publication number
- DK1849774T3 DK1849774T3 DK06713854.5T DK06713854T DK1849774T3 DK 1849774 T3 DK1849774 T3 DK 1849774T3 DK 06713854 T DK06713854 T DK 06713854T DK 1849774 T3 DK1849774 T3 DK 1849774T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclohepta
- pyridine
- same
- product containing
- pharmaceutical product
- Prior art date
Links
- XGQIFNGYTVCLEW-UHFFFAOYSA-N N-(diaminomethylidene)-4H-cyclohepta[b]pyridine-3-carboxamide Chemical class N1=C2C(CC(=C1)C(=O)NC(=N)N)=CC=CC=C2 XGQIFNGYTVCLEW-UHFFFAOYSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005038780 | 2005-02-16 | ||
| PCT/JP2006/302713 WO2006088080A1 (ja) | 2005-02-16 | 2006-02-16 | シクロヘプタ［ｂ］ピリジン－３－カルボニルグアニジン誘導体およびそれを含有する医薬品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1849774T3 true DK1849774T3 (da) | 2011-10-10 |
Family
ID=36916481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06713854.5T DK1849774T3 (da) | 2005-02-16 | 2006-02-16 | Cyclohepta(b)pyridin-3-carbonylguanidinderivat og farmaceutisk produkt indeholdende samme |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7875625B2 (da) |
| EP (1) | EP1849774B1 (da) |
| JP (1) | JP4826983B2 (da) |
| KR (1) | KR101255868B1 (da) |
| CN (1) | CN101119971B (da) |
| AU (1) | AU2006215084B2 (da) |
| CA (1) | CA2598988C (da) |
| DK (1) | DK1849774T3 (da) |
| ES (1) | ES2365531T3 (da) |
| WO (1) | WO2006088080A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5424272B2 (ja) * | 2008-03-26 | 2014-02-26 | トーアエイヨー株式会社 | ９−ヒドロキシメチル−シクロヘプタ［ｂ］ピリジン−３−カルボン酸エステル誘導体の製造方法 |
| AU2009243749B2 (en) * | 2008-05-09 | 2013-11-21 | Merck Patent Gmbh | Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
| JP6876047B2 (ja) * | 2015-09-08 | 2021-05-26 | オーピーツー ドラッグス | ミトコンドリアの活性酸素種（ｒｏｓ）産生に関連する疾患の治療のための化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2089600T3 (es) | 1992-02-15 | 1996-10-01 | Hoechst Ag | Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas. |
| DE4430861A1 (de) | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| JPH08208602A (ja) * | 1994-10-18 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | インドロイルグアニジン誘導体 |
| CA2160600A1 (en) * | 1994-10-18 | 1996-04-19 | Masahumi Kitano | Indoloylguanidine derivatives |
| WO1998039300A1 (en) | 1997-03-06 | 1998-09-11 | Toa Eiyo Ltd. | CYCLOALKA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND DRUGS CONTAINING THE SAME |
| JPH11286454A (ja) | 1998-01-29 | 1999-10-19 | Sumitomo Pharmaceut Co Ltd | 虚血性脳血管障害の治療剤 |
| CA2316944A1 (en) | 1998-02-20 | 1999-08-26 | Mitsuru Shiraishi | Aminoguanidinehydrazone derivative, production and use thereof |
| JP2000191641A (ja) | 1998-02-20 | 2000-07-11 | Takeda Chem Ind Ltd | アミノグアニジンヒドラゾン誘導体、その製法及び剤 |
| WO2001044186A1 (en) | 1999-12-16 | 2001-06-21 | Sumitomo Pharmaceuticals Company, Limited | Substituted guanidine derivatives |
| JP4317233B2 (ja) | 2007-02-26 | 2009-08-19 | 新生精機株式会社 | 建築用シャッターの急降下停止装置 |
-
2006
- 2006-02-16 AU AU2006215084A patent/AU2006215084B2/en not_active Ceased
- 2006-02-16 WO PCT/JP2006/302713 patent/WO2006088080A1/ja not_active Ceased
- 2006-02-16 ES ES06713854T patent/ES2365531T3/es not_active Expired - Lifetime
- 2006-02-16 JP JP2007503693A patent/JP4826983B2/ja not_active Expired - Fee Related
- 2006-02-16 KR KR1020077018533A patent/KR101255868B1/ko not_active Expired - Fee Related
- 2006-02-16 EP EP06713854A patent/EP1849774B1/en not_active Expired - Lifetime
- 2006-02-16 US US11/816,420 patent/US7875625B2/en not_active Expired - Fee Related
- 2006-02-16 DK DK06713854.5T patent/DK1849774T3/da active
- 2006-02-16 CN CN2006800047317A patent/CN101119971B/zh not_active Expired - Fee Related
- 2006-02-16 CA CA2598988A patent/CA2598988C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20090012114A1 (en) | 2009-01-08 |
| KR101255868B1 (ko) | 2013-04-23 |
| EP1849774A4 (en) | 2009-11-25 |
| JP4826983B2 (ja) | 2011-11-30 |
| ES2365531T3 (es) | 2011-10-06 |
| AU2006215084A1 (en) | 2006-08-24 |
| CN101119971A (zh) | 2008-02-06 |
| EP1849774B1 (en) | 2011-06-29 |
| US7875625B2 (en) | 2011-01-25 |
| CA2598988C (en) | 2013-06-25 |
| KR20070107039A (ko) | 2007-11-06 |
| EP1849774A1 (en) | 2007-10-31 |
| WO2006088080A1 (ja) | 2006-08-24 |
| AU2006215084B2 (en) | 2011-03-24 |
| CN101119971B (zh) | 2010-09-08 |
| CA2598988A1 (en) | 2006-08-24 |
| JPWO2006088080A1 (ja) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217916A0 (en) | Pharmaceutical products | |
| SE0303570L (sv) | Fukt-känslig medicinsk produkt | |
| NO20054681D0 (no) | Farmasoytiske produkter | |
| DK2719368T3 (da) | Lægemiddeldispenser og anordning derfor | |
| DK1894567T3 (da) | Ledsagende farmaceutiske midler og anvendelse deraf | |
| FI20030610A0 (fi) | Syötävä tuote | |
| DE602005000476D1 (de) | Extrudiertes Produkt | |
| IL183178A0 (en) | Pharmaceutical product | |
| ATE466925T1 (de) | Duftverfahren und produkt | |
| DK1957073T3 (da) | Lægemiddel | |
| DK1939204T3 (da) | Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf | |
| GB0526332D0 (en) | Pharmaceutical product | |
| DK1608811T3 (da) | Flerlagsprodukt og fremgangsmåde til fremstillingen deraf | |
| DK1658073T3 (da) | Farmaceutisk produkt til injektion | |
| SE0300002L (sv) | Ny produkt | |
| DE602005019009D1 (de) | Verzinntes Produkt | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DE502005003152D1 (de) | Produktbehälter | |
| DK1876916T3 (da) | Produkt | |
| DK1849774T3 (da) | Cyclohepta(b)pyridin-3-carbonylguanidinderivat og farmaceutisk produkt indeholdende samme | |
| DK1791872T3 (da) | Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf | |
| DK1944298T3 (da) | Quinazolinderivat og lægemiddel | |
| GB2447190B (en) | Trihalomethionine derivative and pharmaceutical product containing the same | |
| ATE514680T1 (de) | Cyclohepta(b)pyridin-3-carbonylguanidinderivat und pharmazeutisches produkt, das dieses enthält | |
| NO20054117L (no) | Absorbent produkt og prosess for fremstilling av slik absorbent produkt |